Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
18.90 M
About Evelo Biosciences, Inc.
Sector
CEO
Craig R. Jalbert
Headquarters
Cambridge
Website
Founded
2014
FIGI
BBG00KLJ2SH8
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EVLO is 0.0015 USD — it has increased by 200.00% in the past 24 hours. Watch Evelo Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Evelo Biosciences, Inc. stocks are traded under the ticker EVLO.
EVLO stock has risen by 275.00% compared to the previous week, the month change is a 650.00% rise, over the last year Evelo Biosciences, Inc. has showed a −99.74% decrease.
EVLO reached its all-time high on Jan 28, 2021 with the price of 398.5660 USD, and its all-time low was 0.0001 USD and was reached on Jun 27, 2024. View more price dynamics on EVLO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EVLO stock is 66.67% volatile and has beta coefficient of 73.45. Track Evelo Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Evelo Biosciences, Inc. there?
Today Evelo Biosciences, Inc. has the market capitalization of 9.49 K, it has increased by 11.11% over the last week.
Yes, you can track Evelo Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Evelo Biosciences, Inc. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
No, EVLO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EVLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evelo Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evelo Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evelo Biosciences, Inc. stock shows the sell signal. See more of Evelo Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.